⚠️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.

Androgenetic Alopecia: Causes, Stages, and Treatment Options

Androgenetic alopecia is the most common form of hair loss worldwide, affecting an estimated 50 million men and 30 million women in the United States alone. Often called male-pattern or female-pattern hair loss, this condition is driven by a combination of genetics and hormones — and it tends to progress gradually over time. The good news is that modern medicine offers several evidence-based approaches to slow, stop, or even partially reverse the process. In this guide, we break down what causes androgenetic alopecia, how to recognize its stages, and what hair loss treatments are available today.

What Is Androgenetic Alopecia?

Androgenetic alopecia is a hereditary condition in which hair follicles gradually shrink — a process called follicular miniaturization. Over time, thick terminal hairs are replaced by finer, shorter vellus hairs until follicles eventually stop producing visible hair altogether. Unlike sudden or patchy hair loss, androgenetic alopecia follows predictable patterns and progresses slowly over months and years.

The condition is not a disease in the traditional sense. It does not cause pain, itching, or inflammation in most cases. However, its impact on appearance and self-confidence can be significant. Understanding how it works is the first step toward making informed decisions about treatment.

How It Differs From Other Types of Hair Loss

Not all hair loss is the same. It helps to understand where androgenetic alopecia fits among other conditions:

The key difference with androgenetic alopecia is its gradual, patterned progression driven by hormones and genetic predisposition rather than external damage or immune dysfunction.

Who Gets Androgenetic Alopecia?

Androgenetic alopecia can affect anyone, regardless of ethnicity or background. In men, noticeable thinning often begins in the late 20s or 30s, with roughly 50% of men showing some degree of pattern hair loss by age 50. Women can also develop this condition, though it typically appears later — often around menopause — and follows a different pattern of diffuse thinning rather than a receding hairline.

While age increases the likelihood, some individuals notice early signs in their late teens or early 20s. If you notice changes in your hair density or hairline, consulting a licensed healthcare provider can help determine the cause and guide next steps.

What Causes Androgenetic Alopecia?

Understanding the androgenetic alopecia causes behind this condition requires looking at the interplay between hormones, genetics, and time. No single factor acts alone — it is the combination that drives progressive hair thinning.

The Role of DHT (Dihydrotestosterone)

DHT hair loss is the central mechanism behind androgenetic alopecia. DHT is a potent androgen hormone derived from testosterone through the action of an enzyme called 5-alpha reductase. While DHT plays important roles during development — including the growth of facial hair and deepening of the voice during puberty — it has a destructive effect on genetically susceptible scalp hair follicles.

When DHT binds to androgen receptors in vulnerable follicles, it triggers a process called miniaturization. The growth phase (anagen) of the hair cycle becomes shorter, while the resting phase (telogen) stays the same or lengthens. Over successive cycles, the follicle produces thinner, shorter, and less pigmented hairs until it eventually ceases to produce visible hair.

Not all follicles are equally sensitive to DHT. Follicles on the top and front of the scalp tend to have more androgen receptors, which explains the characteristic pattern of thinning. Hair at the sides and back of the head is typically resistant to DHT, which is why it remains even in advanced stages of hair loss. For a deeper look at how this hormone affects your hair, read our guide on DHT blockers explained.

Genetic Factors

Genetics determine how sensitive your hair follicles are to DHT. The androgen receptor gene, located on the X chromosome, is one of the most studied genetic contributors. Because men inherit their X chromosome from their mother, there is a well-known (though oversimplified) association between maternal grandfather hair loss patterns and a man's risk.

In reality, androgenetic alopecia is polygenic — meaning multiple genes on multiple chromosomes contribute. Research has identified over 200 genetic loci associated with the condition. Family history on either side increases risk, and the more affected relatives you have, the higher the likelihood.

For women, the genetic picture is similar but often more complex, as additional hormonal factors influence when and how the condition manifests.

Hormonal Triggers in Men vs. Women

In men, androgenetic alopecia is driven primarily by circulating androgens — testosterone and its more potent derivative, DHT. Men with higher 5-alpha reductase activity or greater androgen receptor density in their scalps tend to experience earlier and more pronounced hair loss.

In women, the hormonal picture is more nuanced. Estrogen and progesterone have protective effects on hair follicles, which is why many women maintain full hair throughout their reproductive years. When estrogen levels decline — during menopause, after pregnancy, or due to conditions like polycystic ovary syndrome (PCOS) — the relative influence of androgens increases, and hair thinning may begin or accelerate.

Women rarely develop the fully bald patches seen in advanced male-pattern hair loss. Instead, they typically experience a widening part line and overall reduction in hair volume, particularly at the crown.

Stages and Patterns of Androgenetic Alopecia

Clinicians use standardized classification scales to describe the progression of androgenetic alopecia. These help both providers and patients understand the current stage and anticipate future changes.

The Norwood Scale (Men)

The Hamilton-Norwood scale is the most widely used classification system for male-pattern hair loss. It describes seven primary stages:

Treatment tends to be most effective when started at earlier stages (II through IV), before significant follicular miniaturization has occurred.

The Ludwig Scale (Women)

Female-pattern hair loss follows a different progression, classified using the Ludwig scale:

Unlike men, women rarely lose their frontal hairline entirely. The diffuse thinning pattern makes early detection more challenging, which is why paying attention to subtle changes matters.

Early Warning Signs

Catching androgenetic alopecia early improves the chances of successful treatment. Watch for these signs:

If you notice these changes, it does not necessarily mean you have androgenetic alopecia — other conditions can cause similar symptoms. A licensed healthcare provider can help determine the underlying cause.

Diagnosing Androgenetic Alopecia

Diagnosing androgenetic alopecia typically begins with a thorough medical history and physical examination. A healthcare provider will ask about the pattern and timeline of hair loss, family history, medications, and any recent health changes.

In many cases, the diagnosis can be made based on clinical appearance alone — the characteristic pattern of thinning is often unmistakable. However, additional evaluations may be helpful to rule out other causes:

Getting an accurate diagnosis is essential because the right treatment depends on the type and cause of hair loss. A telehealth consultation can be a convenient starting point for evaluation.

Treatment Options for Androgenetic Alopecia

Pattern hair loss treatment has advanced considerably in recent years. While no treatment can fully restore a head of hair to its original state, several evidence-based options can slow progression, promote regrowth, and maintain existing hair. The most effective strategies often combine multiple approaches.

Note: A prescription is not guaranteed. Your licensed provider will evaluate your condition and medical history to determine which treatments, if any, are appropriate for you.

Finasteride and Dutasteride

Finasteride and dutasteride are oral medications that work by inhibiting the enzyme 5-alpha reductase, which converts testosterone into DHT. By reducing DHT levels, these medications slow follicular miniaturization and, in many cases, promote some degree of regrowth.

Finasteride blocks type II 5-alpha reductase, while dutasteride blocks both type I and type II, resulting in a more significant reduction in DHT levels. Both are widely used in clinical practice for pattern hair loss treatment in men.

Potential side effects may include decreased libido, erectile difficulties, and mood changes in a small percentage of users. These effects are generally reversible upon stopping the medication. Women who are pregnant or may become pregnant should not handle crushed or broken tablets due to the risk of birth defects.

To understand the differences between these two medications in more detail, check out our comparison of finasteride vs dutasteride.

Minoxidil

Minoxidil is a topical solution or foam applied directly to the scalp. It works by increasing blood flow to hair follicles and prolonging the growth phase of the hair cycle. Unlike finasteride, minoxidil does not affect DHT levels — it supports hair growth through a different mechanism.

Minoxidil is available over the counter in 2% and 5% concentrations. It is used by both men and women and is typically applied once or twice daily. Results usually take three to six months to become noticeable, and continued use is necessary to maintain benefits.

Common side effects include scalp irritation, dryness, and in some cases, temporary increased shedding during the first few weeks of use (a phenomenon sometimes called "the minoxidil shed"). This initial shedding is generally considered a sign that the treatment is working, as old hairs are pushed out to make way for new growth.

Combination Therapy

Many providers recommend combining treatments for better results. A common approach pairs an oral DHT blocker like finasteride with topical minoxidil. This strategy addresses hair loss from two different angles — reducing the hormonal driver while simultaneously stimulating follicle activity.

Other combinations may include:

Your licensed provider can help design a combination approach tailored to your specific situation and medical history.

Emerging Treatments

The field of hair loss treatment continues to evolve. Several newer approaches are being studied or used in select clinical settings:

As research advances, new options will continue to emerge. Staying informed and working with a knowledgeable provider ensures you have access to the most current approaches.

Ready to Address Your Hair Loss?

Connect with a licensed provider through Truventa Medical to discuss evidence-based hair loss treatments tailored to your needs. Prescription not guaranteed — your provider will evaluate your condition first.

Explore Hair Loss Treatments

Living With Androgenetic Alopecia: What to Expect

Androgenetic alopecia is a progressive condition, which means it will continue to advance without intervention. However, with consistent treatment, many people are able to maintain their current hair and experience meaningful regrowth — especially when they start early.

Here are a few practical considerations for managing the condition long term:

Understanding androgenetic alopecia empowers you to take action on your own terms. Whether you choose active treatment, a watch-and-wait approach, or simply want to understand what is happening, knowledge is the foundation. If you are experiencing hair thinning, a conversation with a licensed healthcare provider is a worthwhile first step toward finding the approach that works best for you.

Truventa Medical is a technology platform that connects patients with independent licensed healthcare providers through OpenLoop Health. Truventa does not directly provide medical services, prescribe medications, or establish a doctor-patient relationship. All clinical decisions are made by your licensed provider.